University of Wisconsin, Madison
This study is being done to evaluate the clinical utilization and safety of RayStation 2025 and RayCare 2025 treatment planning software upgrades when used to support standard-of-care proton therapy delivery in patients deemed clinically appropriate for such therapy by their treating radiation oncologist.
In this study, the radiation treatment itself, including target definitions, prescription dose, treatment delivery, verification imaging, and adaptive treatment planning, is standard of care. Current standard radiation therapy planning is based on a treatment plan generated from a planning computed tomography (CT) scan obtained before treatment begins. This plan is generally used for the entire course of therapy, with verification imaging performed during treatment primarily used to verify patient positioning rather than to recalculate delivered dose. On occasion, it is standard practice for…
Inclusion Criteria: * Age less than or equal to 17 years at the time of consent/assent. * Patient has a clinical indication for radiation therapy, and the treating radiation oncologist has independently determined that proton therapy is clinically appropriate and has recommended proton therapy as part of the patient's routine clinical care, independent of participation in this research study. Proton therapy may be delivered with or without anesthesia when clinically indicated. * Written informed consent will be obtained from adult subjects or the parent/legal guardian of pediatric subjects. A…
Part of a not yet FDA-cleared software, the RaySearch treatment planning system and RayCare oncology information system. RayTracker enables longitudinal evaluation of treatment by recalculating dose on daily images and accumulating dose across fractions using deformable image registration, thereby providing an estimate of the cumulative delivered dose to targets and organs at risk. RayAdaptive uses daily treatment imaging (such as cone-beam CT (CBCT)) together with the planning CT to generate an updated representation of patient anatomy and recalculation of dose on the current patient anatomy, allowing clinicians to evaluate whether anatomical changes could meaningfully alter the planned dose distribution. These features are designed to be used in tandem. Their combined capabilities are intended to support clinical decision-making related to treatment monitoring and potential adaptation.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.